Chen, X., Zang, Y., Li, D., Guo, J., Wang, Y., Lin, Y., & Wei, Z. (2020). IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era. Medicine (Baltimore).

Chen, Xiangli, Yuzhu Zang, Dujuan Li, Jianmin Guo, Yacai Wang, Yuqi Lin, und Zhenghong Wei. "IDO, TDO, and AHR Overexpression Is Associated With Poor Outcome in Diffuse Large B-cell Lymphoma Patients in the Rituximab Era." Medicine (Baltimore) 2020.

Chen, Xiangli, et al. "IDO, TDO, and AHR Overexpression Is Associated With Poor Outcome in Diffuse Large B-cell Lymphoma Patients in the Rituximab Era." Medicine (Baltimore) 2020.